Dottikon Exclusive Synthesis AG

DOTTIKON manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the worlds leading chemical, biotech, and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 110 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, as well as reduce energy consumption, waste, and CO2 emissions sustainably....

Sicherheitskritische reaktion,veredelungschemikalien,exklusivwirkstoffe,zwischenprodukte,and gmp/iso

Dottikon exclusive synthesis ag operates in the Chemical manufacturing industry.

Dottikon exclusive synthesis ag's revenue is 101m - 500m

Dottikon exclusive synthesis ag has 201 - 500 employees.